Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology

Objectives: Bisphosphonates (BPs) are powerful inhibitors of osteoclastogenesis and are used to prevent osteoporotic bone loss and reduce the risk of osteoporotic fracture in patients suffering from postmenopausal osteoporosis. Patients with breast cancer or gynecological malignancies being treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jayoung, Yeon, Austin, Parker, Sarah J., Shahid, Muhammad, Thiombane, Aissatou, Cho, Eunho, You, Sungyong, Emam, Hany, Kim, Do-Gyoon, Kim, Minjung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364444/
https://www.ncbi.nlm.nih.gov/pubmed/34400895
http://dx.doi.org/10.7150/ijms.61552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364444/
https://www.ncbi.nlm.nih.gov/pubmed/34400895
http://dx.doi.org/10.7150/ijms.61552

Ejemplares similares